Lv2
170 积分 2023-12-01 加入
Single Inhibitors versus Dual Inhibitors: Role of HDAC in Cancer
20天前
已完结
Acetylation increases expression, interaction with TRAPPC4 and surface localization of PD-L1
20天前
已完结
Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor
25天前
已完结
Tumor immunity: a novel dimension for PROTACs to conquer cancer?
26天前
已完结
USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ
26天前
已完结
Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling
26天前
已完结
Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor
26天前
已完结
PROTAC‐Mediated HDAC7 Protein Degradation Unveils Its Deacetylase‐Independent Proinflammatory Function in Macrophages
26天前
已完结
Discovery of Novel HDAC3 Inhibitors with PD-L1 Downregulating/Degrading and Antitumor Immune Effects
27天前
已完结
Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses
27天前
已完结
皖公网安备34019202002308
